Europe Molecular Diagnostics Market

Europe Molecular Diagnostics Market (Product: Real-time PCR Systems, Liquid Handling Systems, and DNA Extraction Systems) - Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2024-2034

Europe Molecular Diagnostics Market Outlook 2034

  • The industry in the region was valued at US$ 5.9 Bn in 2023
  • It is estimated to advance at a CAGR of 10.2% from 2024 to 2034 and reach US$ 17.3 Bn by the end of 2034

Analyst Viewpoint

Rise in prevalence of infectious diseases such a tuberculosis and hepatitis along with sexually transmitted infections (STIs) such as chlamydia and gonorrhea is propelling the Europe molecular diagnostics market growth. Molecular diagnostic methods assist in early detection and treatment of infectious illnesses, allowing healthcare personnel to offer the best care and monitoring.

Development of molecular medicine innovations focused on personalized medicine is another prominent factor boosting the Europe molecular diagnostics market size. Personalized medicines are tailored therapeutic approaches based on individual patient characteristics, preferences, and comfort.

These are assisted by molecular diagnostics, as they allow for adequate time for treatment, monitoring, and recovery. Prominent market players are fostering strategic partnerships and acquiring smaller players to maintain their stronghold in the competitive region.

Europe Molecular Diagnostics Market Analysis

Molecular diagnostics is a term encompassing a set of approaches or techniques specially designed to analyze biological markers, such as body temperature and gene sequencing, at a molecular level to detect and identify mutations, pathogens, or markers for rare disorders.

Molecular testing technology utilizes microarray analysis and nucleic acid amplification to treat cancer, infectious diseases, and genetic disorders.

Advantages of molecular diagnostics include high specificity and precision, fast turnaround time, enhanced automation, and sensitive detection of low levels of pathogens or mutations.

Recent Europe molecular diagnostics market trends suggest a shift in focus toward personalized medicine and therapeutic treatment options.

Integration of point-of-care digital testing platforms and next-generation sequencing is gaining traction in the healthcare system in Europe, owing to the rise in the burden of infectious diseases in the region.

Attribute Detail
Market Drivers
  • Rise in Prevalence of Infectious Diseases
  • Advancements in Personalized Medicine

Increase in Prevalence of Infectious Diseases Fueling Market Progress

Incidence of infectious diseases such as HIV, tuberculosis, hepatitis, and sexually transmitted diseases (STDs) has been rising across the globe. This is creating lucrative molecular diagnostic market opportunities in Europe.

Precision diagnostics facilitate rapid and accurate detection of pathogens, which enables early diagnosis of illnesses. This allows medical professionals to plan the treatment in a personalized manner and spend adequate time on disease management.

Growth in migration to Europe, evolving antimicrobial resistance, and globalization are augmenting the need for timely detection, identification, treatment, and management of illnesses, thus advancing Europe molecular diagnostics market statistics.

According to the European Centre for Disease Prevention and Control, the region witnessed 23 million new infection cases of sexually transmitted diseases (STDs) in 2021. Chlamydia and Gonorrhea are infections prevalent in the region.

Advancements in Personalized Medicine Bolstering Europe Molecular Diagnostics Market Revenue

Molecular diagnostics advancements in Europe focus primarily on personalized medicines that refer to tailored treatment approaches influenced by individual traits and preferences of each patient.

Personalized medicine advancements in molecular diagnostics include growing applications in prenatal screening and liquid biopsy adoption in order to predict a patient’s response and monitor treatment efficacy.

Implementation challenges of molecular diagnostics in European healthcare systems include high costs associated with development of novel technologies and investments in specialized education of skilled professionals.

Regulations and policy framework involve European Union-wide standardization of molecular diagnostic practices across healthcare contexts, which is challenging based on the current transition state of healthcare infrastructure.

As per the European Commission, more than EUR 3.0 Bn has been spent on personalized medicine research and implementation in the EU in recent years.

Country Outlook

Attribute Detail
Leading Country Germany

Germany accounted for the largest Europe molecular diagnostics market share in 2023. Increase in investments in biotechnology research and growth in government support for accessible healthcare are factors fueling the market dynamics of the country.

According to Bio Deutschland, R&D expenditure in the biotechnology and diagnostic sector witnessed a growth of 54.0% in 2021 compared to previous years, with investments amounting to nearly EUR 3.8 Bn.

As per the latest Europe molecular diagnostics market forecast, the industry in Spain is projected to grow at a steady pace during the period between 2024 and 2034. Rise in geriatric population, increase in migration toward urban centers, and growth in private investment in biotechnology are fostering market development in the country.

According to data made publicly available by the Government of Spain, 9.68 million people aged over 65 years reside in the country. In 2021, the government spent about 7.3% of total GDP on healthcare technology and access.

Analysis of Key Players

Companies operating in the Europe molecular diagnostics industry are investing significantly in development of infectious disease surveillance using molecular diagnostics and molecular pathology. These investments aim to meet the increase in demand driven by surge in migration and growing geriatric population.

Close collaborations with other firms and outsourcing are strategies that enable companies in the Europe molecular diagnostics market to expand their product portfolio. Merger & acquisition is also a key tactic implemented by the leading players to maintain their stronghold in the constantly evolving regional landscape.

Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Inc., Danaher, Eppendorf SE, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Tecan Trading AG, Thermo Fisher Scientific, Inc., and QIAGEN are dominant firms operating in this sector.

The Europe molecular diagnostics market report highlights parameters such as company overview, financial overview, product portfolio, business strategies, and business segments of the companies mentioned above.

Key Developments

  • In March 2024, Bio-Techne Corporation, a leading biotechnology firm, announced that its flagship product, Asuragen, a diagnostic test to monitor chronic myeloid leukemia, had received the class C certification under the European Union’s new IVDR certification
  • In September 2022, SkylineDx, a prominent molecular diagnostics company, announced the launch of Merlin Assay as CE-IVD distributable test kit in Europe. The product detects and identifies melanoma (skin cancer) patients that have a low risk for nodal metastasis and therefore can safely stay alive without a sentinel lymph node biopsy (SLNB) surgery.

Europe Molecular Diagnostics Market Snapshot

Attribute Detail
Market Value in 2023 (Base Year) US$ 5.9 Bn
Market Forecast Value in 2034 US$ 17.3 Bn
Growth Rate (CAGR) 10.2%
Forecast Period 2024-2034
Historical Data Available for 2020-2022
Quantitative Units US$ Bn for Value and Units for Volume
Market Analysis The qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the country level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape
  • Prominent Players - Competition Dashboard and Revenue Share Analysis, 2023
  • Company Profiles (Details - Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Format Electronic (PDF) + Excel
Market Segmentation
  • Product
    • Real-time PCR Systems
      • LightCycler 480
      • PCRmax Eco 48
      • Applied Biosystems 7900HT
      • QuantStudio Real-Time PCR
      • ViiA 7 Real-time PCR
      • C1000 Touch
      • ABI StepOnePlus Real-time PCR
      • 5ABI 7500
      • AriaMx Real-time PCR System
      • CFX Connect
      • CFX384 Touch
      • MiniOpticon
      • Others
    • Liquid Handling Systems
      • epMotion
      • Biomek
      • Freedom EVO
      • Tecan D300e Digital Dispenser
      • Precision
      • JANUS
      • Others
    • DNA Extraction Systems
      • AutoMate Express
      • QIAcube
      • InnuPure
      • VERSA
      • Chemagic
      • Others
  • End-user
    • Hospitals
    • Diagnostics Laboratories
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
Countries Covered
  • U.K.
  • France
  • Spain
  • Germany
  • Italy
Companies Profiled
  • Agilent Technologies, Inc.
  • BD
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer, Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific, Inc.
  • QIAGEN
Customization Scope Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the Europe molecular diagnostics market in 2023?

It was valued at US$ 5.9 Bn in 2023

How is the Europe molecular diagnostics business expected to grow by 2034?

It is projected to grow at a CAGR of 10.2% from 2024 to 2034

What are the key factors driving the demand for molecular diagnostics in Europe?

Rise in prevalence of infectious diseases and advancements in personalized medicine

Which was the major country in the Europe molecular diagnostics industry in 2023?

Germany dominated the regional landscape in 2023

Who are the key molecular diagnostic manufacturers in Europe?

Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Inc., Danaher, Eppendorf SE, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Tecan Trading AG, Thermo Fisher Scientific, Inc., and QIAGEN

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Europe Molecular Diagnostics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Europe Molecular Diagnostics Market Analysis and Forecast, 2020-2034

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Europe Molecular Diagnostics Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product, 2020-2034

            6.3.1. Real-time PCR Systems

                6.3.1.1. LightCycler 480

                6.3.1.2. PCRmax Eco 48

                6.3.1.3. Applied Biosystems 7900HT

                6.3.1.4. QuantStudio Real-Time PCR

                6.3.1.5. ViiA 7 Real-Time PCR

                6.3.1.6. C1000 Touch

                6.3.1.7. ABI StepOnePlus Real-Time PCR

                6.3.1.8. 5ABI 7500

                6.3.1.9. AriaMx Real-time PCR System

                6.3.1.10. CFX Connect

                6.3.1.11. CFX384 Touch

                6.3.1.12. MiniOpticon

                6.3.1.13. Others

            6.3.2. Liquid Handling Systems

                6.3.2.1. epMotion

                6.3.2.2. Biomek

                6.3.2.3. Freedom EVO

                6.3.2.4. Tecan D300e Digital Dispenser

                6.3.2.5. Precision

                6.3.2.6. JANUS

                6.3.2.7. Others

            6.3.3. DNA Extraction Systems

                6.3.3.1. AutoMate Express

                6.3.3.2. QIAcube

                6.3.3.3. InnuPure

                6.3.3.4. VERSA

                6.3.3.5. Chemagic

                6.3.3.6. Others

        6.4. Market Attractiveness Analysis, by Product

    7. Europe Molecular Diagnostics Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by End-user, 2020-2034

            7.3.1. Hospitals

            7.3.2. Diagnostics Laboratories

            7.3.3. Academic & Research Institutes

            7.3.4. Pharmaceutical & Biotechnology Companies

        7.4. Market Attractiveness Analysis, by End-user

    8. Europe Molecular Diagnostics Market Analysis and Forecast, by Country

        8.1. Key Findings

        8.2. Market Value Forecast, by Country, 2020-2034

            8.2.1. Italy

            8.2.2. Europe

            8.2.3. U.K.

            8.2.4. France

            8.2.5. Germany

        8.3. Market Attractiveness Analysis, by Country

    9. Italy Molecular Diagnostics Market Analysis and Forecast

        9.1. Introduction

        9.2. Key Findings

        9.3. Market Value Forecast, by Product, 2020-2034

            9.3.1. Real-time PCR Systems

                9.3.1.1. LightCycler 480

                9.3.1.2. PCRmax Eco 48

                9.3.1.3. Applied Biosystems 7900HT

                9.3.1.4. QuantStudio Real-Time PCR

                9.3.1.5. ViiA 7 Real-Time PCR

                9.3.1.6. C1000 Touch

                9.3.1.7. ABI StepOnePlus Real-Time PCR

                9.3.1.8. 5ABI 7500

                9.3.1.9. AriaMx Real-time PCR System

                9.3.1.10. CFX Connect

                9.3.1.11. CFX384 Touch

                9.3.1.12. MiniOpticon

                9.3.1.13. Others

            9.3.2. Liquid Handling Systems

                9.3.2.1. epMotion

                9.3.2.2. Biomek

                9.3.2.3. Freedom EVO

                9.3.2.4. Tecan D300e Digital Dispenser

                9.3.2.5. Precision

                9.3.2.6. JANUS

                9.3.2.7. Others

            9.3.3. DNA Extraction Systems

                9.3.3.1. AutoMate Express

                9.3.3.2. QIAcube

                9.3.3.3. InnuPure

                9.3.3.4. VERSA

                9.3.3.5. Chemagic

                9.3.3.6. Others

        9.4. Market Value Forecast, by End-user, 2020-2034

            9.4.1. Hospitals

            9.4.2. Diagnostics Laboratories

            9.4.3. Academic & Research Institutes

            9.4.4. Pharmaceutical & Biotechnology Companies

        9.5. Market Value Forecast, by Country, 2020-2034

            9.5.1. U.S.

            9.5.2. Canada

        9.6. Market Attractiveness Analysis

            9.6.1. By Product

            9.6.2. By End-user

    10. Spain Molecular Diagnostics Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Product, 2020-2034

            10.3.1. Real-time PCR Systems

                10.3.1.1. LightCycler 480

                10.3.1.2. PCRmax Eco 48

                10.3.1.3. Applied Biosystems 7900HT

                10.3.1.4. QuantStudio Real-Time PCR

                10.3.1.5. ViiA 7 Real-Time PCR

                10.3.1.6. C1000 Touch

                10.3.1.7. ABI StepOnePlus Real-Time PCR

                10.3.1.8. 5ABI 7500

                10.3.1.9. AriaMx Real-time PCR System

                10.3.1.10. CFX Connect

                10.3.1.11. CFX384 Touch

                10.3.1.12. MiniOpticon

                10.3.1.13. Others

            10.3.2. Liquid Handling Systems

                10.3.2.1. epMotion

                10.3.2.2. Biomek

                10.3.2.3. Freedom EVO

                10.3.2.4. Tecan D300e Digital Dispenser

                10.3.2.5. Precision

                10.3.2.6. JANUS

                10.3.2.7. Others

            10.3.3. DNA Extraction Systems

                10.3.3.1. AutoMate Express

                10.3.3.2. QIAcube

                10.3.3.3. InnuPure

                10.3.3.4. VERSA

                10.3.3.5. Chemagic

                10.3.3.6. Others

        10.4. Market Value Forecast, by End-user, 2020-2034

            10.4.1. Hospitals

            10.4.2. Diagnostics Laboratories

            10.4.3. Academic & Research Institutes

            10.4.4. Pharmaceutical & Biotechnology Companies

        10.5. Market Attractiveness Analysis

            10.5.1. By Product

            10.5.2. By End-user

    11. U.K. Molecular Diagnostics Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Product, 2020-2034

            11.3.1. Real-time PCR Systems

                11.3.1.1. LightCycler 480

                11.3.1.2. PCRmax Eco 48

                11.3.1.3. Applied Biosystems 7900HT

                11.3.1.4. QuantStudio Real-Time PCR

                11.3.1.5. ViiA 7 Real-Time PCR

                11.3.1.6. C1000 Touch

                11.3.1.7. ABI StepOnePlus Real-Time PCR

                11.3.1.8. 5ABI 7500

                11.3.1.9. AriaMx Real-time PCR System

                11.3.1.10. CFX Connect

                11.3.1.11. CFX384 Touch

                11.3.1.12. MiniOpticon

                11.3.1.13. Others

            11.3.2. Liquid Handling Systems

                11.3.2.1. epMotion

                11.3.2.2. Biomek

                11.3.2.3. Freedom EVO

                11.3.2.4. Tecan D300e Digital Dispenser

                11.3.2.5. Precision

                11.3.2.6. JANUS

                11.3.2.7. Others

            11.3.3. DNA Extraction Systems

                11.3.3.1. AutoMate Express

                11.3.3.2. QIAcube

                11.3.3.3. InnuPure

                11.3.3.4. VERSA

                11.3.3.5. Chemagic

                11.3.3.6. Others

        11.4. Market Value Forecast, by End-user, 2020-2034

            11.4.1. Hospitals

            11.4.2. Diagnostics Laboratories

            11.4.3. Academic & Research Institutes

            11.4.4. Pharmaceutical & Biotechnology Companies

        11.5. Market Attractiveness Analysis

            11.5.1. By Product

            11.5.2. By End-user

    12. France Molecular Diagnostics Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Product, 2020-2034

            12.3.1. Real-time PCR Systems

                12.3.1.1. LightCycler 480

                12.3.1.2. PCRmax Eco 48

                12.3.1.3. Applied Biosystems 7900HT

                12.3.1.4. QuantStudio Real-Time PCR

                12.3.1.5. ViiA 7 Real-Time PCR

                12.3.1.6. C1000 Touch

                12.3.1.7. ABI StepOnePlus Real-Time PCR

                12.3.1.8. 5ABI 7500

                12.3.1.9. AriaMx Real-time PCR System

                12.3.1.10. CFX Connect

                12.3.1.11. CFX384 Touch

                12.3.1.12. MiniOpticon

                12.3.1.13. Others

            12.3.2. Liquid Handling Systems

                12.3.2.1. epMotion

                12.3.2.2. Biomek

                12.3.2.3. Freedom EVO

                12.3.2.4. Tecan D300e Digital Dispenser

                12.3.2.5. Precision

                12.3.2.6. JANUS

                12.3.2.7. Others

            12.3.3. DNA Extraction Systems

                12.3.3.1. AutoMate Express

                12.3.3.2. QIAcube

                12.3.3.3. InnuPure

                12.3.3.4. VERSA

                12.3.3.5. Chemagic

                12.3.3.6. Others

        12.4. Market Value Forecast, by End-user, 2020-2034

            12.4.1. Hospitals

            12.4.2. Diagnostics Laboratories

            12.4.3. Academic & Research Institutes

            12.4.4. Pharmaceutical & Biotechnology Companies

        12.5. Market Attractiveness Analysis

            12.5.1. By Product

            12.5.2. By End-user

    13. Germany Molecular Diagnostics Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Product, 2020-2034

            13.3.1. Real-time PCR Systems

                13.3.1.1. LightCycler 480

                13.3.1.2. PCRmax Eco 48

                13.3.1.3. Applied Biosystems 7900HT

                13.3.1.4. QuantStudio Real-Time PCR

                13.3.1.5. ViiA 7 Real-Time PCR

                13.3.1.6. C1000 Touch

                13.3.1.7. ABI StepOnePlus Real-Time PCR

                13.3.1.8. 5ABI 7500

                13.3.1.9. AriaMx Real-time PCR System

                13.3.1.10. CFX Connect

                13.3.1.11. CFX384 Touch

                13.3.1.12. MiniOpticon

                13.3.1.13. Others

            13.3.2. Liquid Handling Systems

                13.3.2.1. epMotion

                13.3.2.2. Biomek

                13.3.2.3. Freedom EVO

                13.3.2.4. Tecan D300e Digital Dispenser

                13.3.2.5. Precision

                13.3.2.6. JANUS

                13.3.2.7. Others

            13.3.3. DNA Extraction Systems

                13.3.3.1. AutoMate Express

                13.3.3.2. QIAcube

                13.3.3.3. InnuPure

                13.3.3.4. VERSA

                13.3.3.5. Chemagic

                13.3.3.6. Others

        13.4. Market Value Forecast, by End-user, 2020-2034

            13.4.1. Hospitals

            13.4.2. Diagnostics Laboratories

            13.4.3. Academic & Research Institutes

            13.4.4. Pharmaceutical & Biotechnology Companies

        13.5. Market Attractiveness Analysis

            13.5.1. By Product

            13.5.2. By End-user

    14. Competition Landscape

        14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        14.2. Market Share Analysis, by Company (2023)

        14.3. Company Profiles

            14.3.1. Agilent Technologies, Inc.

                14.3.1.1. Company Overview

                14.3.1.2. Product Portfolio

                14.3.1.3. SWOT Analysis

                14.3.1.4. Financial Overview

                14.3.1.5. Strategic Overview

            14.3.2. BD

                14.3.2.1. Company Overview

                14.3.2.2. Product Portfolio

                14.3.2.3. SWOT Analysis

                14.3.2.4. Financial Overview

                14.3.2.5. Strategic Overview

            14.3.3. Bio-Rad Laboratories, Inc.

                14.3.3.1. Company Overview

                14.3.3.2. Product Portfolio

                14.3.3.3. SWOT Analysis

                14.3.3.4. Financial Overview

                14.3.3.5. Strategic Overview

            14.3.4. Danaher

                14.3.4.1. Company Overview

                14.3.4.2. Product Portfolio

                14.3.4.3. SWOT Analysis

                14.3.4.4. Financial Overview

                14.3.4.5. Strategic Overview

            14.3.5. Eppendorf SE

                14.3.5.1. Company Overview

                14.3.5.2. Product Portfolio

                14.3.5.3. SWOT Analysis

                14.3.5.4. Financial Overview

                14.3.5.5. Strategic Overview

            14.3.6. F. Hoffmann-La Roche Ltd.

                14.3.6.1. Company Overview

                14.3.6.2. Product Portfolio

                14.3.6.3. SWOT Analysis

                14.3.6.4. Financial Overview

                14.3.6.5. Strategic Overview

            14.3.7. PerkinElmer, Inc.

                14.3.7.1. Company Overview

                14.3.7.2. Product Portfolio

                14.3.7.3. SWOT Analysis

                14.3.7.4. Financial Overview

                14.3.7.5. Strategic Overview

            14.3.8. Tecan Trading AG

                14.3.8.1. Company Overview

                14.3.8.2. Product Portfolio

                14.3.8.3. SWOT Analysis

                14.3.8.4. Financial Overview

                14.3.8.5. Strategic Overview

            14.3.9. Thermo Fisher Scientific, Inc.

                14.3.9.1. Company Overview

                14.3.9.2. Product Portfolio

                14.3.9.3. SWOT Analysis

                14.3.9.4. Financial Overview

                14.3.9.5. Strategic Overview

            14.3.10. QIAGEN

                14.3.10.1. Company Overview

                14.3.10.2. Product Portfolio

                14.3.10.3. SWOT Analysis

                14.3.10.4. Financial Overview

                14.3.10.5. Strategic Overview

    List of Tables

    Table 01: Europe Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 02: Europe Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034

    Table 03: Europe Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 04: Europe Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country, 2020-2034

    Table 05: Italy Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 06: Italy Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034

    Table 07: Italy Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 08: Italy Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country, 2020-2034

    Table 09: Spain Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 10: Spain Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034

    Table 11: Spain Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 12: Spain Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 13: U.K. Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 14: U.K. Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034

    Table 15: U.K. Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 16: U.K. Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 17: France Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 18: France Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034

    Table 19: France Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 20: France Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 21: Germany Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034

    Table 22: Germany Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034

    Table 23: Germany Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 24: Germany Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    List of Figures

    Figure 01: Europe Molecular Diagnostics Market Size (US$ Mn) and Distribution (%), by Country, 2023 and 2034

    Figure 02: Europe Molecular Diagnostics Market Revenue (US$ Mn), by Product, 2023

    Figure 03: Europe Molecular Diagnostics Market Value Share, by Product, 2023

    Figure 04: Europe Molecular Diagnostics Market Revenue (US$ Mn), by End-user, 2023

    Figure 05: Europe Molecular Diagnostics Market Value Share, by End-user, 2023

    Figure 06: Europe Molecular Diagnostics Market Value Share, by Country, 2023

    Figure 07: Europe Molecular Diagnostics Market Value (US$ Mn) Forecast, 2023-2034

    Figure 08: Europe Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

    Figure 09: Europe Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034

    Figure 10: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 11: Europe Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034

    Figure 12: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2023 and 2034

    Figure 13: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country, 2023-2034

    Figure 14: Italy Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

    Figure 15: Italy Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

    Figure 16: Italy Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 17: Italy Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034

    Figure 18: Italy Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034

    Figure 19: Spain Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

    Figure 20: Spain Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

    Figure 21: Spain Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 22: Spain Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034

    Figure 23: Spain Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034

    Figure 24: U.K. Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

    Figure 25: U.K. Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

    Figure 26: U.K. Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 27: U.K. Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034

    Figure 28: U.K. Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034

    Figure 29: France Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

    Figure 30: France Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

    Figure 31: France Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 32: France Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034

    Figure 33: France Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034

    Figure 34: Germany Molecular Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

    Figure 35: Germany Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

    Figure 36: Germany Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

    Figure 37: Germany Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034

    Figure 38: Germany Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034

Copyright © Transparency Market Research, Inc. All Rights reserved